HomeRIGL • NASDAQ
add
Rigel Pharmaceuticals Inc
Previous close
$16.25
Day range
$15.50 - $16.31
Year range
$7.48 - $29.82
Market cap
286.24M USD
Avg Volume
283.94K
P/E ratio
75.00
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 55.31M | 96.58% |
Operating expense | 27.04M | 8.80% |
Net income | 12.42M | 318.22% |
Net profit margin | 22.46 | 211.02% |
Earnings per share | 0.70 | 333.33% |
EBITDA | 14.67M | 451.47% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 61.11M | -1.98% |
Total assets | 139.42M | 20.89% |
Total liabilities | 154.06M | 4.69% |
Total equity | -14.64M | — |
Shares outstanding | 17.62M | — |
Price to book | -19.58 | — |
Return on assets | 26.24% | — |
Return on capital | 45.06% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 12.42M | 318.22% |
Cash from operations | 21.68M | 1,695.22% |
Cash from investing | 3.80M | 424.96% |
Cash from financing | -9.84M | -1,032.57% |
Net change in cash | 15.64M | 560.24% |
Free cash flow | 6.85M | 40.05% |
About
Founded
1996
Headquarters
Website
Employees
147
